Article

Optimized Multiple Amplification Protocol for the Production of Allogeneic Human Vγ9Vδ2 T Lymphocytes for Adoptive Cell Transfer Immunotherapy

2026-03-30

Abstract excerpt

<h4>ABSTRACT</h4> Cancer remains a major therapeutic challenge despite substantial advances in diagnosis and treatment, including immune checkpoint blockade. Among emerging immunotherapeutic approaches, adoptive cell transfer (ACT) has attracted growing interest. Human peripheral Vγ9Vδ2 T cells are promising candidates for ACT because they combine rapid and potent antitumor functions with major histocompatibility...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8e9a526f-f854-5897-a168-b5c89d5b0eba
DOI: 10.64898/2026.03.25.714172

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Optimized Multiple Amplification Protocol for the Production of Allogeneic Human Vγ9Vδ2 T Lymphocytes for Adoptive Cell Transfer ImmunotherapyDOI 10.64898/2026.03.25.714172Read

Serum free expansion and transduction of human Vγ9δ2 T cells for adoptive immunotherapySemantic proximity Read

Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapySemantic proximity Read

The antitumor activity of human Vγ9Vδ2 T cells is impaired by TGF-β through significant phenotype, transcriptomic and metabolic changes.Semantic proximity Read

A dramatic impairment of the antitumor activity of human Vγ9Vδ2 T cells is induced by TGF-β through significant phenotype, transcriptomic and metabolic changesSemantic proximity Read

A closed, autologous bioprocess optimized for TCR-T cell therapiesSemantic proximity Read

Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells.Semantic proximity Read

Single-cell RNA sequencing of human double-negative T cells reveals a favorable cellular signature for cancer therapySemantic proximity Read

Development of Ingenui-T, a Novel Vein-to-Vein Solution for Rapid Autologous CAR T-Cell Manufacturing Starting From Whole Blood, for the Treatment of Autoimmune DiseasesSemantic proximity Read

Differentiating PD-1+ stem-like CD8 T cells towards distinct effectors with enhanced therapeutic potential by an engineered IL-2 cis-targeted to PD-1Semantic proximity Read

A Novel Cell Therapy for COVID-19 and Potential Future Pandemics: Virus Induced Lymphocytes (VIL)Semantic proximity Read

Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor AntigensSemantic proximity Read

SUCCESSFUL MANUFACTURING OF CLINICAL-GRADE SARS-CoV-2 SPECIFIC T CELLS FOR ADOPTIVE CELL THERAPYSemantic proximity Read